/AIFF
AIFF Stock - Firefly Neuroscience, Inc.
Technology|Software - ApplicationNASDAQ
$1.34+3.88%
+$0.05 (+3.88%) • Dec 19
43
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.44
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.47
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AIFF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.33 – $1.35
TARGET (TP)$1.54
STOP LOSS$1.23
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.89
52W High$17.20
52W Low$1.25
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $108,000 | $498,000 | N/A | $32,000 | $13.90M |
| Gross Profit | $41,000 | $498,000 | N/A | $32,000 | $2.21M |
| Gross Margin | 38.0% | 100.0% | N/A | 100.0% | 15.9% |
| Operating Income | $-9,180,000 | $-3,078,000 | $-3,329,000 | $-4,654,000 | $411,848 |
| Net Income | $-10,460,000 | $-2,603,000 | $-3,789,000 | $-4,381,000 | $413,379 |
| Net Margin | -9685.2% | -522.7% | N/A | -13690.6% | 3.0% |
| EPS | $-1.60 | $-0.33 | $-0.48 | $-0.56 | $0.05 |
Company Overview
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AIFFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.20
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 12, 2025 | — | $-0.20 | — | — |
Q3 2025 | Aug 13, 2025 | — | $-0.14 | — | — |
Q2 2025 | May 14, 2025 | — | $-1.30 | — | — |
Q2 2025 | Apr 3, 2025 | — | $-0.45 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.61 | — | — |
Q3 2024 | Aug 19, 2024 | — | $-0.58 | — | — |
Q2 2024 | May 14, 2024 | — | $-0.33 | — | — |
Q1 2024 | Mar 31, 2024 | — | $-1.00 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.08 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.03 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.12 | — | — |
Latest News
Firefly Neuroscience Files For Mixed Shelf Of Up To $250M
➖ NeutralBenzinga•Dec 3, 2025, 10:05 PM
Firefly Neuroscience Q3 EPS $(0.20) Up From $(0.61) YoY, Sales $388.000K Up From $33.000K YoY
📈 PositiveBenzinga•Nov 12, 2025, 12:53 PM
Firefly Partners With HealingMaps To Supply FDA-Cleared EEG Analytics To Psychedelic Clinics Through Healing Health Alliance GPO
📈 PositiveBenzinga•Sep 5, 2025, 12:00 PM
Firefly Neuroscience shares are trading higher after the company announced the launch of its AI-powered CLEAR platform.
📈 PositiveBenzinga•Aug 26, 2025, 12:47 PM
Firefly Neuroscience Launches AI-Powered CLEAR Platform To Deliver Cleaner, Faster EEG Data Using NVIDIA GPUs
📈 PositiveBenzinga•Aug 26, 2025, 11:49 AM•Also:
Frequently Asked Questions about AIFF
What is AIFF's current stock price?
Firefly Neuroscience, Inc. (AIFF) is currently trading at $1.34 per share. The stock has moved +3.88% today.
What is the analyst price target for AIFF?
No analyst price targets are currently available for this stock.
What sector is Firefly Neuroscience, Inc. in?
Firefly Neuroscience, Inc. operates in the Technology sector, specifically within the Software - Application industry. The company is traded on the NASDAQ exchange.
What is AIFF's market cap?
Firefly Neuroscience, Inc. has a market capitalization of $0.02 billion, making it a small-cap company.
Does AIFF pay dividends?
No, Firefly Neuroscience, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Technology SectorANY
Sphere 3D Corp.
$0.37
Mkt Cap: $0.0B
ARBE
Arbe Robotics Ltd.
$1.18
Mkt Cap: $0.1B
CNTM
ConnectM Technology Solutions, Inc.
$0.48
Mkt Cap: $0.0B
CXAI
CXApp Inc.
$0.39
Mkt Cap: $0.0B
MNDO
MIND C.T.I. Ltd
$1.16
Mkt Cap: $0.0B
NTCL
NetClass Technology Inc
$0.66
Mkt Cap: $0.0B
NXPL
NextPlat Corp
$0.61
Mkt Cap: $0.0B
RMSG
Real Messenger Corporation
$1.57
Mkt Cap: $0.0B
SAGT
SAGTEC GLOBAL Ltd
$2.08
Mkt Cap: $0.0B
VEEA
Veea Inc.
$0.73
Mkt Cap: $0.0B
Explore stocks similar to AIFF for comparison